BALATON Study (Protocol number: GR41984)

A 72 weeks study, Phase III, multicenter, randomized, double-masked, active comparator-controlled study to evaluate the efficacy, safety and pharmacokinetics of Faricimab (RO6867461) administered by intravitreal (IVT) injection in patients with macular oedema secondary to branch retinal vein occlusion (BRVO).

ClinicalTrials.gov Identifier: NCT04740905

Principal Investigator: Dr Balaratnasingam, Chandra

For further information about this study, you may visit Clinical Trial Registry: https://clinicaltrials.gov/ct2/show/NCT04740905?term=2020-000440-63&draw=2&rank=1

Or contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email clinicalresearch@lei.org.au

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment